Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison B Goldfine

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemiaWaleed Aldhahi, Jen Armstrong, Clara Bouche, et al.
Acta Diabetologica|October 15, 2014
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort studySeoyoung C Kim, Robert J Glynn, Jun Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2011
Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acidsXimena Lopez, Aaron Cypess, Raquel Manning, et al.
Obesity (Silver Spring, Md.)|March 31, 2006
Peptide YY levels are elevated after gastric bypass surgeryJean L Chan, Edward C Mun, Violeta Stoyneva, et al.
Diabetes|January 26, 2012
Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humansFlorencia Halperin, Ximena Lopez, Raquel Manning, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 14, 2016
IMPROVEMENTS IN METABOLIC CONTROL IN ADULTS WITH TYPE 2 DIABETES FOLLOWING REFERRAL TO A DIABETES CENTER, 2005-2010Sanjeev N Mehta, Allison B Goldfine, Martin J Abrahamson, et al.
Circulation Research|January 12, 2002
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humansJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Journal of Diabetes Science and Technology|February 27, 2013
Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluationSanjeev N Mehta, Allison B Goldfine, Martin J Abrahamson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2010
Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetesJoshua A Beckman, Allison B Goldfine, Alison Goldin, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|January 15, 2020
Adjustable gastric band surgery or medical management in patients with type 2 diabetes and obesity: three-year results of a randomized trialDonald C Simonson, Ashley Vernon, Kathleen Foster, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemiaWaleed Aldhahi, Jen Armstrong, Clara Bouche, et al.
Acta Diabetologica|October 15, 2014
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort studySeoyoung C Kim, Robert J Glynn, Jun Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2011
Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acidsXimena Lopez, Aaron Cypess, Raquel Manning, et al.
Obesity (Silver Spring, Md.)|March 31, 2006
Peptide YY levels are elevated after gastric bypass surgeryJean L Chan, Edward C Mun, Violeta Stoyneva, et al.
Diabetes|January 26, 2012
Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humansFlorencia Halperin, Ximena Lopez, Raquel Manning, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 14, 2016
IMPROVEMENTS IN METABOLIC CONTROL IN ADULTS WITH TYPE 2 DIABETES FOLLOWING REFERRAL TO A DIABETES CENTER, 2005-2010Sanjeev N Mehta, Allison B Goldfine, Martin J Abrahamson, et al.
Circulation Research|January 12, 2002
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humansJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Journal of Diabetes Science and Technology|February 27, 2013
Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluationSanjeev N Mehta, Allison B Goldfine, Martin J Abrahamson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2010
Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetesJoshua A Beckman, Allison B Goldfine, Alison Goldin, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|January 15, 2020
Adjustable gastric band surgery or medical management in patients with type 2 diabetes and obesity: three-year results of a randomized trialDonald C Simonson, Ashley Vernon, Kathleen Foster, et al.
Pageof 14